HKEX Stock Code: 01093English|繁體|简体

2024 1H Results

  • Revenue RMB16,284M, +1.3%
  • Underlying profit attributable to shareholders RMB3,217M, +1.7%
  • Reported profit attributable to shareholders RMB3,020M, +1.8%
  • Basic earnings per share (reported) RMB25.51 cents, +2.2%
  • Basic earnings per share (underlying profit) RMB27.17 cents, +2.2%

Highlight - 2024 1H

Revenue
RMB16,284M, +1.3%
Underlying profit attributable to shareholders
RMB3,217M, +1.7%
Reported profit attributable to shareholders
RMB3,020M, +1.8%
Basic earnings per share (reported)
RMB25.51 cents, +2.2%
Basic earnings per share (underlying profit)
RMB27.17 cents, +2.2%

Corporate Governance

Corporate Governance

Financial Calendar

Aug
21
Aug
21
May
28
May
27
May
27
Mar
20
Mar
20

Financial Reports

Financial Reports

Financial Summary

Financial Summary

IR Contacts

Address : Suite 3206, 32/F, Central Plaza,
18 Harbour Road, Wanchai, Hong Kong
Tel : (852) 2500 3144
Fax : (852) 2802 4552
E-mail : ir@cspc.hk
© Copyright 2024 CSPC Pharmaceutical Group Limited. All Rights Reserved.